Real-time enrollment status for this diabetic macular edema clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 7:12 PM UTC
| NCT Number | NCT06962839 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Macular Edema |
| Phase | PHASE2 |
| Target Enrollment | 300 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT06962839 is currently recruiting participants. This phase2 study for diabetic macular edema is actively seeking new participants at 33 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06962839 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06962839 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.